Exercise therapy in polycystic ovary syndrome: a systematic review

被引:159
|
作者
Harrison, Cheryce L. [1 ]
Lombard, Catherine B. [1 ,2 ]
Moran, Lisa J. [1 ]
Teede, Helena J. [1 ,2 ]
机构
[1] Monash Univ, Monash Med Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3168, Australia
[2] So Hlth, Diabetes Unit, Melbourne, Vic 3168, Australia
关键词
polycystic ovary syndrome; exercise; lifestyle modification; weight; insulin resistance; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; OBESE WOMEN; WEIGHT-LOSS; METABOLIC SYNDROME; DIABETES-MELLITUS; TRAINING-PROGRAM; OVERWEIGHT WOMEN; GLYCEMIC CONTROL; SKELETAL-MUSCLE;
D O I
10.1093/humupd/dmq045
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine disorder, affecting 8-12% of women. Lifestyle modification, including increased physical activity, is the first-line approach in managing PCOS. A systematic review was performed to identify and describe the effect of exercise as an independent intervention on clinical outcomes in PCOS. METHODS: Five databases were searched with no time limit. A pre-specified definition of PCOS was not used. Studies were included if exercise therapy (aerobic and/or resistance) could be evaluated as an independent treatment against a comparison group. Outcomes measured included cardiovascular risk factors [insulin resistance (IR), lipid profiles, blood pressure and weight] and reproductive measures (ovulation, menstrual regularity and fertility outcomes). Quality analysis was performed based on the Cochrane Handbook of Systematic Reviews and the Quality of Reporting of Meta-Analyses checklist. RESULTS: Eight manuscripts were identified (five randomized controlled trials and three cohort studies). All studies involved moderate intensity physical activity and most were of either 12 or 24 weeks duration with frequency and duration of exercise sessions ranging between studies. The most consistent improvements included improved ovulation, reduced IR (9-30%) and weight loss (4.5-10%). Improvements were not dependant on the type of exercise, frequency or length of exercise sessions. CONCLUSIONS: Exercise-specific interventions in PCOS are limited. Studies vary considerably in design, intensity and outcome measures; therefore conclusive results remain elusive. Larger, optimally designed studies are needed to both gain insights into the mechanisms of exercise action and to evaluate the public health impact of exercise of PCOS.
引用
收藏
页码:171 / 183
页数:13
相关论文
共 50 条
  • [1] Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis
    Kite, Chris
    Lahart, Ian M.
    Afzal, Islam
    Broom, David R.
    Randeva, Harpal
    Kyrou, Ioannis
    Brown, James E.
    SYSTEMATIC REVIEWS, 2019, 8 (1)
  • [2] Exercise and Polycystic Ovary Syndrome
    Woodward, Amie
    Klonizakis, Markos
    Broom, David
    PHYSICAL EXERCISE FOR HUMAN HEALTH, 2020, 1228 : 123 - 136
  • [3] Androgens in Polycystic Ovary Syndrome: The Role of Exercise and Diet
    Giallauria, Francesco
    Palomba, Stefano
    Vigorito, Carlo
    Tafuri, Maria Giovanna
    Colao, Annamaria
    Lombardi, Gaetano
    Orio, Francesco
    SEMINARS IN REPRODUCTIVE MEDICINE, 2009, 27 (04) : 306 - 315
  • [4] Effects of Metformin and Exercise in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
    Song, Yu
    Wang, Huimin
    Zhu, Zhengyan
    Huang, Hongli
    HORMONE AND METABOLIC RESEARCH, 2021, 53 (11) : 738 - 745
  • [5] The effect of dietary carbohydrates in women with polycystic ovary syndrome: a systematic review
    Frary, Johanna M. C.
    Bjerre, Kamilla P.
    Glintborg, Dorte
    Ravn, Penille
    MINERVA ENDOCRINOLOGICA, 2016, 41 (01) : 57 - 69
  • [6] Exercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
    Patten, Rhiannon K.
    Boyle, Russell A.
    Moholdt, Trine
    Kiel, Ida
    Hopkins, William G.
    Harrison, Cheryce L.
    Stepto, Nigel K.
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [7] Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
    Bril, Fernando
    Ezeh, Uche
    Amiri, Mina
    Hatoum, Sana
    Pace, Lauren
    Chen, Yen-Hao
    Bertrand, Fred
    Gower, Barbara
    Azziz, Ricardo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (01) : 10 - 24
  • [8] Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis
    Naderpoor, Negar
    Shorakae, Soulmaz
    de Courten, Barbora
    Misso, Marie L.
    Moran, Lisa J.
    Teede, Helena J.
    HUMAN REPRODUCTION UPDATE, 2015, 21 (05) : 560 - 574
  • [9] Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes
    Ortiz-Flores, Andres E.
    Luque-Ramirez, Manuel
    Escobar-Morreale, Hector F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) : 1915 - 1926
  • [10] Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society
    Moran, Lisa J.
    Pasquali, Renato
    Teede, Helena J.
    Hoeger, Kathleen M.
    Norman, Robert J.
    FERTILITY AND STERILITY, 2009, 92 (06) : 1966 - 1982